In addition, high frequencies of gene mutations or deletions of PBRM1 (36%), SETD2 (15%), BAP1 (13%), and KDM5C (7%) have also been identified in the ccRCC (29). This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.